Lauren Seeberger

4.2k total citations · 1 hit paper
31 papers, 2.5k citations indexed

About

Lauren Seeberger is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Lauren Seeberger has authored 31 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Cognitive Neuroscience. Recurrent topics in Lauren Seeberger's work include Neurological disorders and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Lauren Seeberger is often cited by papers focused on Neurological disorders and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Lauren Seeberger collaborates with scholars based in United States, Switzerland and Australia. Lauren Seeberger's co-authors include Randall C. O’Reilly, Michael J. Frank, Robert A. Hauser, Christopher O’Brien, Lisa M. Deuel, Eric Molho, Stewart A. Factor, Charles H. Adler, Theresa Zesiewicz and Jeffrey Friedlander and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Lauren Seeberger

27 papers receiving 2.4k citations

Hit Papers

By Carrot or by Stick: Cognitive Reinforcement Learning i... 2004 2026 2011 2018 2004 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren Seeberger United States 17 1.2k 1.1k 734 330 213 31 2.5k
Alice W. Flaherty United States 17 772 0.7× 874 0.8× 820 1.1× 169 0.5× 225 1.1× 36 2.1k
Nicola J. Ray United Kingdom 26 1.7k 1.5× 979 0.9× 1.1k 1.5× 283 0.9× 100 0.5× 55 2.9k
Ji Hyun Ko Canada 33 1.2k 1.1× 1.2k 1.1× 602 0.8× 364 1.1× 174 0.8× 91 3.0k
Beatrice A. Summers United Kingdom 12 1.2k 1.0× 1.2k 1.1× 619 0.8× 424 1.3× 150 0.7× 13 2.5k
Imis Dogan Germany 23 508 0.4× 1.2k 1.0× 408 0.6× 288 0.9× 228 1.1× 47 2.0k
Marcus Heldmann Germany 27 596 0.5× 1.1k 1.0× 372 0.5× 183 0.6× 361 1.7× 122 2.2k
Oscar S. Gershanik Argentina 34 2.5k 2.1× 981 0.9× 1.5k 2.0× 454 1.4× 211 1.0× 83 4.1k
Atbin Djamshidian Austria 29 1.9k 1.6× 585 0.5× 774 1.1× 262 0.8× 98 0.5× 99 3.0k
Rebekka Lencer Germany 30 548 0.5× 1.1k 1.0× 404 0.6× 758 2.3× 259 1.2× 114 2.5k
Simon Červenka Sweden 26 345 0.3× 781 0.7× 445 0.6× 619 1.9× 284 1.3× 81 2.4k

Countries citing papers authored by Lauren Seeberger

Since Specialization
Citations

This map shows the geographic impact of Lauren Seeberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Seeberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Seeberger more than expected).

Fields of papers citing papers by Lauren Seeberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Seeberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Seeberger. The network helps show where Lauren Seeberger may publish in the future.

Co-authorship network of co-authors of Lauren Seeberger

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Seeberger. A scholar is included among the top collaborators of Lauren Seeberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Seeberger. Lauren Seeberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ying, Jacquelyn Bainbridge, Stefan Sillau, et al.. (2024). Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Movement Disorders. 39(5). 863–875. 10 indexed citations
2.
Forbes, Eric G., et al.. (2024). Perceptions of palliative care in Huntington's disease: A qualitative study. Parkinsonism & Related Disorders. 120. 106007–106007.
3.
Lester, Evan, et al.. (2024). Using a mixed-reality headset to elicit and track clinically relevant movement in the clinic. Journal of Neuroscience Methods. 415. 110349–110349.
4.
Rummey, Christian, Louise A. Corben, Martin B. Delatycki, et al.. (2022). Natural History of Friedreich Ataxia. Neurology. 99(14). e1499–e1510. 33 indexed citations
5.
Rummey, Christian, John M. Flynn, Louise A. Corben, et al.. (2021). Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort. Annals of Clinical and Translational Neurology. 8(6). 1239–1250. 17 indexed citations
6.
Leehey, Maureen A., Ying Liu, Mary Ann Cook, et al.. (2020). Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis and Cannabinoid Research. 5(4). 326–336. 53 indexed citations
7.
Yohrling, George J., et al.. (2020). Prevalence of Huntington’s Disease in the US (954). Neurology. 94(15_supplement). 9 indexed citations
8.
Deuel, Lisa M. & Lauren Seeberger. (2020). Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis. Neurotherapeutics. 17(4). 1434–1455. 72 indexed citations
9.
Piquet, Amanda L., Judith E. A. Warner, Matthew Wicklund, et al.. (2019). Novel clinical features of glycine receptor antibody syndrome. Neurology Neuroimmunology & Neuroinflammation. 6(5). e592–e592. 41 indexed citations
10.
Seeberger, Lauren, et al.. (2011). Rasagiline. The Neurologist. 17(6). 318–324. 7 indexed citations
11.
Buck, Philip O., et al.. (2011). Examination of the UPDRS Bradykinesia Subscale: Equivalence, Reliability and Validity. Journal of Parkinson s Disease. 1(3). 253–258. 15 indexed citations
12.
Hall, Deborah A., et al.. (2009). MOVEMENT DISORDERS ASSOCIATED WITH ARIPIPRAZOLE USE: A CASE SERIES. International Journal of Neuroscience. 119(12). 2274–2279. 15 indexed citations
13.
Seeberger, Lauren & Robert A. Hauser. (2007). Optimizing bioavailability in the treatment of Parkinson's disease. Neuropharmacology. 53(7). 791–800. 19 indexed citations
14.
Corboy, John R., et al.. (2006). MS vs. HD: Can white matter and subcortical gray matter pathology be distinguished neuropsychologically?. Journal of Clinical and Experimental Neuropsychology. 29(2). 142–154. 16 indexed citations
15.
Truong, Daniel, Drake D. Duane, Joseph Jankovic, et al.. (2005). Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study. Movement Disorders. 20(7). 783–791. 179 indexed citations
16.
Frank, Michael J., Lauren Seeberger, & Randall C. O’Reilly. (2004). By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism. Science. 306(5703). 1940–1943. 1437 indexed citations breakdown →
17.
McRae, Cynthia, Gretchen Diem, Alexander H. Vo, Christopher O’Brien, & Lauren Seeberger. (2002). Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings. Parkinsonism & Related Disorders. 8(3). 187–192. 60 indexed citations
18.
O’Brien, Christopher, Allison Brashear, Paul A. Cullis, et al.. (2001). Cervical dystonia severity scale reliability study. Movement Disorders. 16(6). 1086–1090. 31 indexed citations
19.
Trosch, Richard, Joseph H. Friedman, Rajesh Pahwa, et al.. (1998). Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience. Movement Disorders. 13(3). 377–382. 97 indexed citations
20.
O’Brien, Christopher, Lauren Seeberger, & Don B. Smith. (1996). Spasticity After Stroke. Drugs & Aging. 9(5). 332–340. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026